Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies

Azzam Hamad1, Gaukhar M Yusubalieva2,3, Vladimir P Baklaushev2,3

  • 1Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.

Viruses
|February 28, 2023
PubMed

Insights

Oncolytic viruses (OVs) show promise for treating aggressive glioblastoma when standard therapies fail. Combining OVs with other treatments could significantly improve patient survival and represents a key research area.

Area of Science:

  • Neuro-oncology
  • Virology
  • Immunotherapy

Background:

  • Glioblastoma is an aggressive brain tumor with poor prognosis.
  • Current treatments like standard protocols and immunotherapy offer limited long-term survival benefits.

Purpose of the Study:

  • To review oncolytic virus (OV) therapy for glioblastomas.
  • To explore the potential of combining OVs with other therapeutic modalities.

Main Methods:

  • Review of existing literature on virotherapy for glioblastomas.
  • Identification and description of various OVs.
  • Analysis of OV combinations with other treatment options.

Main Results:

  • Oncolytic viruses (OVs) present a potential alternative to conventional glioblastoma treatments.
  • Combinations of OVs with other therapies may enhance treatment efficacy.
  • Personalized approaches integrating OVs are emerging.

Conclusions:

  • Virotherapy, particularly with oncolytic viruses, offers a promising avenue for glioblastoma treatment.
  • Combination strategies and personalized medicine are crucial for advancing glioblastoma therapy.
  • Further research into OV combinations is essential for developing effective treatment regimens.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
611
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
103
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
468
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K